Harbour Investments’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Harbour Investments’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$701K	Sell	7,077 -26	-0.4%	-$2.34K	0.01%	964
2026 Q1	$616K	Buy	7,103 +5,304	+295%	+$464K	0.01%	959
2025 Q4	$153K	Buy	1,799 +1,300	+261%	+$104K	﹤0.01%	1420
2025 Q3	$36.2K	Hold	499	–	–	﹤0.01%	2042
2025 Q2	$32.7K	Buy	499 +61	+14%	+$3.97K	﹤0.01%	2008
2025 Q1	$30.9K	Buy	438 +138	+46%	+$9.59K	﹤0.01%	1990
2024 Q4	$19.7K	Hold	300	–	–	﹤0.01%	2133
2024 Q3	$21.2K	Hold	300	–	–	﹤0.01%	2028
2024 Q2	$19.9K	Sell	300 -18	-6%	-$1.18K	﹤0.01%	1957
2024 Q1	$21.6K	Hold	318	–	–	﹤0.01%	1919
2023 Q4	$19.7K	Hold	318	–	–	﹤0.01%	1885
2023 Q3	$18.8K	Hold	318	–	–	﹤0.01%	1768
2023 Q2	$19K	Hold	318	–	–	﹤0.01%	1777
2023 Q1	$18.6K	Buy	318 +18	+6%	+$1.08K	﹤0.01%	1773
2022 Q4	$18.6K	Hold	300	–	–	﹤0.01%	1711
2022 Q3	$19K	Hold	300	–	–	﹤0.01%	1673
2022 Q2	$19K	Buy	+300	New	+$19K	﹤0.01%	1673
2021 Q4	$21K	Sell	309 -54	-15%	-$3.42K	﹤0.01%	1650
2021 Q3	$22K	Hold	363	–	–	﹤0.01%	2247
2021 Q2	$22K	Buy	363 +300	+476%	+$18.2K	﹤0.01%	2293
2021 Q1	$4K	Buy	+63	New	+$3.8K	﹤0.01%	2982

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Harbour Investments's IHE Position: Q2 2026 in Review

Harbour Investments reduced its iShares US Pharmaceuticals ETF (IHE) stake by 0.37% in Q2 2026, selling an estimated $2.34K and leaving 7,077 shares worth $701K. The position accounts for 0.01% of the portfolio, ranked #964.

Harbour Investments first reported a position in IHE in Q1 2021 and has held it in 21 quarters since. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

Harbour Investments held 7,077 shares of iShares US Pharmaceuticals ETF worth $701K as of Q2 2026.
Harbour Investments sold 26 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $2.34K.
iShares US Pharmaceuticals ETF made up 0.01% of Harbour Investments's portfolio in Q2 2026, its #964 holding.
Harbour Investments first reported a position in iShares US Pharmaceuticals ETF in Q1 2021 and has held it in 21 quarters since.
209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.